Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-05-04 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2022 年年度股东大会决议公告" which translates to "2022 Annual General Meeting Resolution Announcement." It details the date and location of the shareholders' meeting, attendance, voting results on various proposals including the annual report, audit institution appointment, financial statements, profit distribution plan, director and supervisor remuneration, internal control evaluation, and amendments to the company charter. It also includes legal witness statements confirming the legality of the meeting and voting procedures. The document is a formal announcement of the voting results and resolutions passed at the Annual General Meeting (AGM). It does not contain the full annual report or financial statements themselves but reports on the outcomes of the AGM votes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5274 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2023-05-04 Chinese
北京市中伦律师事务所关于北京诺禾致源科技股份有限公司2022年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the 2022 Annual General Meeting (AGM) of Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the procedures of convening, holding, attendance, and voting results of the AGM. The document does not contain financial statements or detailed financial performance data but focuses on the legality and procedural correctness of the AGM and its resolutions. This matches the description of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is over 5,000 characters and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2023-05-04 Chinese
北京诺禾致源科技股份有限公司2022年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as the "2022 Annual General Meeting (AGM) materials" for Beijing Novogene Technology Co., Ltd. It contains detailed agenda items for the 2022 AGM, including reports such as the 2022 Board of Directors Work Report, Independent Directors' Report, 2022 Financial Final Accounts Report, Profit Distribution Plan, and other proposals to be voted on at the AGM. The document includes meeting instructions, agenda, and attachments of reports to be discussed at the AGM. It is clearly a set of materials prepared for the Annual General Meeting, not the Annual Report itself or any other type of filing. The length is substantial (15,000 characters), consistent with detailed AGM materials. Therefore, the document fits the category of AGM Information (AGM-R).
2023-04-17 Chinese
北京诺禾致源科技股份有限公司股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company Beijing 诺禾致源科技股份有限公司. It details the stock price movements over specific dates, the company's internal investigation, confirmations from controlling shareholders, and risk warnings to investors. There is no financial data, no detailed financial report, no earnings summary, no management discussion, nor any mention of a report being attached or published. The document is a regulatory announcement about stock trading behavior and compliance with stock exchange rules, fitting the category of a Regulatory Filing (RNS). The document length is short (1590 characters), and it is clearly an announcement rather than a full report or presentation.
2023-04-14 Chinese
关于北京诺禾致源科技股份有限公司股票交易异常波动的询证函的回函
Regulatory Filings Classification · 95% confidence The document is a response letter to an inquiry about abnormal stock trading fluctuations. It states that the controlling shareholder is not planning any major corporate actions such as mergers, share issuance, or asset restructuring, and confirms no insider trading during the period. The content is a regulatory response to a stock trading inquiry rather than a financial report or announcement of a corporate event. It does not contain financial data, management changes, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2023-04-14 Chinese
北京诺禾致源科技股份有限公司独立董事对公司对外担保情况的专项说明
Regulatory Filings Classification · 95% confidence The document is a special statement by independent directors regarding the company's external guarantees for the year 2022. It references regulatory requirements from the China Securities Regulatory Commission and company bylaws, and provides an independent opinion on compliance and the absence of illegal guarantees. The document is short (691 characters) and focuses on a specific regulatory compliance matter related to external guarantees, signed by independent directors. It is not a full audit report, annual report, or financial statement, but rather a regulatory compliance statement by directors. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2023-04-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.